Improving the quality of life in patients with allergic rhinitis induced by cotton dust allergen through sublingual immunotherapy

Q3 Medicine

Allergo Journal International Pub Date : 2025-05-23 DOI:10.1007/s40629-025-00331-1

Nam Thanh Quan, Uyen Hanh Tran, Thuan Duc Nghiem, Thuc MinhVu

{"title":"Improving the quality of life in patients with allergic rhinitis induced by cotton dust allergen through sublingual immunotherapy","authors":"Nam Thanh Quan,  Uyen Hanh Tran,  Thuan Duc Nghiem,  Thuc MinhVu","doi":"10.1007/s40629-025-00331-1","DOIUrl":null,"url":null,"abstract":"Allergic Rhinitis (AR) caused by cotton dust allergen (CDA) is recognized as an occupational disease that significantly impairs both personal and social aspects of life, ultimately diminishing quality of life (QOL). Prolonged inhalation of cotton dust not only triggers AR but is also frequently associated with bronchial asthma, compounding respiratory difficulties. Symptoms such as sneezing, runny nose, nasal congestion, insomnia, headaches, and loss of concentration can reduce work productivity and limit social interactions, often leading to feelings of inferiority, behavioural changes, and mood disturbances. In severe cases, chronic stress may develop, resulting in further economic loss due to decreased efficiency and increased absenteeism. The cumulative impact of these symptoms disrupts daily functioning, social participation, and emotional well-being, highlighting the need for effective preventive and management strategies for individuals exposed to cotton dust in occupational settings.To assess the impact of sublingual immunotherapy (SLIT) on the QOL of patients who have received treatment for 36 months.A total of 52 patients received SILT treatment for 3 years; QOL was assessed after 6, 12, 24, and 36 months.The study demonstrated that SILT improves QOL for AR patients over 36 months, managing occupational allergies.","PeriodicalId":37457,"journal":{"name":"Allergo Journal International","volume":"35 2","pages":"54 - 64"},"PeriodicalIF":0.0000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergo Journal International","FirstCategoryId":"1085","ListUrlMain":"https://link.springer.com/article/10.1007/s40629-025-00331-1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

Allergic Rhinitis (AR) caused by cotton dust allergen (CDA) is recognized as an occupational disease that significantly impairs both personal and social aspects of life, ultimately diminishing quality of life (QOL). Prolonged inhalation of cotton dust not only triggers AR but is also frequently associated with bronchial asthma, compounding respiratory difficulties. Symptoms such as sneezing, runny nose, nasal congestion, insomnia, headaches, and loss of concentration can reduce work productivity and limit social interactions, often leading to feelings of inferiority, behavioural changes, and mood disturbances. In severe cases, chronic stress may develop, resulting in further economic loss due to decreased efficiency and increased absenteeism. The cumulative impact of these symptoms disrupts daily functioning, social participation, and emotional well-being, highlighting the need for effective preventive and management strategies for individuals exposed to cotton dust in occupational settings.

To assess the impact of sublingual immunotherapy (SLIT) on the QOL of patients who have received treatment for 36 months.

A total of 52 patients received SILT treatment for 3 years; QOL was assessed after 6, 12, 24, and 36 months.

The study demonstrated that SILT improves QOL for AR patients over 36 months, managing occupational allergies.

查看原文本刊更多论文

舌下免疫治疗改善棉尘过敏原致变应性鼻炎患者的生活质量

由棉花粉尘过敏原（CDA）引起的过敏性鼻炎（AR）是公认的一种严重损害个人和社会生活方面的职业病，最终降低生活质量（QOL）。长时间吸入棉尘不仅会引发AR，还经常与支气管哮喘有关，从而加剧呼吸困难。打喷嚏、流鼻涕、鼻塞、失眠、头痛和注意力不集中等症状会降低工作效率，限制社交互动，往往导致自卑感、行为改变和情绪紊乱。在严重的情况下，慢性压力可能会发展，导致进一步的经济损失，由于效率下降和缺勤增加。这些症状的累积影响会扰乱日常功能、社会参与和情绪健康，因此需要对在职业环境中接触棉尘的个人采取有效的预防和管理策略。目的探讨舌下免疫治疗（SLIT）对治疗36个月患者生活质量的影响。共有52例患者接受了3年的淤泥治疗；分别于6、12、24、36个月后评估生活质量。研究表明，淤泥改善AR患者36个月以上的生活质量，管理职业过敏。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Allergo Journal International Medicine-Immunology and Allergy

CiteScore

4.60

自引率

0.00%

发文量

期刊介绍： Allergo Journal International is the official Journal of the German Society for Applied Allergology (AeDA) and the Austrian Society for Allergology and Immunology (ÖGAI). The journal is a forum for the communication and exchange of ideas concerning the various aspects of allergy (including related fields such as clinical immunology and environmental medicine) and promotes German allergy research in an international context. The aim of Allergo Journal International is to provide state of the art information for all medical and scientific disciplines that deal with allergic, immunological and environmental diseases. Allergo Journal International publishes original articles, reviews, short communications, case reports, and letters to the editor. The articles cover topics such as allergic, immunological and environmental diseases, the latest developments in diagnosis and therapy as well as current research work concerning antigens and allergens and aspects related to occupational and environmental medicine. In addition, it publishes clinical guidelines and position papers approved by expert panels of the German, Austrian and Swiss Allergy Societies. All submissions are reviewed in single-blind fashion by at least two reviewers. Originally, the journal started as a German journal called Allergo Journal back in 1992. Throughout the years, English articles amounted to a considerable portion in Allergo Journal. This was one of the reasons to extract the scientific content and publish it in a separate journal. Hence, Allergo Journal International was born and now is the international continuation of the original German journal. Nowadays, all original content is published in Allergo Journal International first. Later, selected manuscripts will be translated and published in German and included in Allergo Journal.